2m 2m 2m 2m 2m 2m 2m
KINIKSA PHARMA (KNSA)
NASDAQ
$59.39+$2.26 (+3.96%)
Price as of Jun 23, 2026 4:59 PM EDT- $2.4BMarket Cap
- 98.92%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
KINIKSA PHARMA (KNSA)
$59.39+$2.26 (+3.96%)
KNSA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $57.13 | ||
Change | +$2.02 (+3.67%) | ||
Open | $55.69 | ||
High | $57.81 | ||
Low | $55.69 | ||
Previous Close | $55.11 | ||
Volume | 609,113 | ||
30-Day Average Volume | 554,301 | ||
1-Week Change | 9.15% | ||
1-Month Change | 7.31% | ||
1-Year Change | 98.92% | ||
3-Year Change | 258.18% | ||
5-Year Change | 299.79% | ||
Fundamentals | |||
Shares Outstanding | 42.0M | ||
Total Assets | $825.3M | ||
Market Cap | $2.4B | ||
Enterprise Value | $2.2B | ||
Period: QTR TTM FY | |||
Revenue | $214.3M | ||
Net Income | $22.6M | ||
Free Cash Flow | $50.0M | ||
EBIT | $32.7M | ||
EBITDA | $33.1M | ||
Net Working Capital | $437.6M | ||
EPS | $0.27 | ||
Enterprise Value/EBITDA | 67 | ||
Enterprise Value/Revenue | 10 | ||
P/B | 4 | ||
P/E | 212 | ||
PEG | 4 | ||
Price/Free Cash Flow | 48 | ||
Price/Operating Cash Flow | 48 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue